Both NAPSI and N-NAIL provide accurate cutoffs, but better accuracy seen ...

Complete response rate was 37 percent, and post-hoc end point of ...

64.4 percent of patients with postinflammatory hyperpigmented lesions at baseline experienced ...

Findings seen among both those previously treated for cancer and cancer-naive ...

Suggestive increases for prostate and colorectal cancer mortality observed with more ...

Strong recommendations presented for tapinarof cream, roflumilast cream, lebrikizumab, nemolizumab with ...

Systematic review and network meta-analysis included 93 trials evaluating 42 interventions ...

High levels of anxiety, depression, stigma, and impaired QoL reported by ...

By Denise Mann HealthDay Reporter THURSDAY, July 24, 2025 (HealthDay News) ...

By Denise Mann HealthDay Reporter TUESDAY, July 22, 2025 (HealthDay News) ...